Nav: Home

Role of protein in pancreatic secretion suggests potential method for treating diabetes

December 08, 2016

Research reveals opposing roles for SNAP23 protein in the enzyme- and hormone-secretion functions of the pancreas; SNAP23 inhibitor increased insulin secretion in mice, suggesting potential use as a novel therapy for diabetes

Osaka, Japan - Movement of secretory molecules, such as hormones and digestive enzymes, out of the cell is known as exocytosis. This process is guided by SNARE proteins, which help the fusion of secretory vesicles with the plasma membrane. Thirty-eight human SNARE proteins have been identified, each with its own tissue expression and intracellular localization. One such SNARE, SNAP25, is particularly well characterized, being involved in the release of neurotransmitters as well as insulin secretion from pancreatic β cells. The closely related SNAP23 protein promotes vesicle fusion in many nonneuronal cells, including pancreatic cells, although its exact role depends on the cell type. The pancreas has both exocrine (digestive enzyme secretion through ducts) and endocrine (hormone secretion into the blood) functions, and SNAP23 was known to participate in the endocrine function of pancreatic β cells and the exocrine function of acinar cells in the laboratory. However, the in vivo function of SNAP23 was unknown.

To investigate this, a team of researchers led by Masataka Kunii, Akihiro Harada at Osaka University together with collaborators across Japan developed two mouse models with the Snap23 gene specifically knocked out in either β cells or acinar cells. The study was reported in The Journal of Cell Biology.

Loss of SNAP23 in acinar cells produced mice with reduced exocytosis of inactive digestive enzymes and lower secretion levels of the enzyme amylase. Conversely, loss of SNAP23 in β cells increased the frequency with which insulin vesicles fused with the plasma membrane, enhancing their secretion. These findings suggested opposite roles for SNAP23 in the endocrine and exocrine pancreas.

Because of the similarity between SNAP23 and SNAP25, the two SNAREs compete with each other for binding to other proteins. However, complexes containing SNAP23 are less stable than those with SNAP25, and less efficient at promoting vesicle fusion with the membrane. The researchers exploited this to show the disruption of SNAP23 enabled more SNAP25-containing complexes to form which enhanced processes, such as hormone secretion, that are reliant on vesicle-membrane fusion.

Extrapolating from this, the team predicted that SNAP23 inhibitors could be used as a novel treatment for diabetes by increasing insulin secretion. They screened a library of compounds and identified one, MF286, which bound specifically to SNAP23 but not SNAP25. MF286 was shown to increase insulin secretion both in vitro and in vivo and to improve glucose tolerance by blocking formation of the SNAP23-containing SNARE complex. It also reduced amylase secretion from pancreatic acinar cells, suggesting that it could be used to treat both pancreatitis and diabetes.
-end-
The article, "Opposing roles for SNAP23 in secretion in exocrine and endocrine pancreatic cells" was published in The Journal of Cell Biology at DOI: 10.1038/jcb.201604030

Osaka University

Related Diabetes Articles:

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Clint Smith
The killing of George Floyd by a police officer has sparked massive protests nationwide. This hour, writer and scholar Clint Smith reflects on this moment, through conversation, letters, and poetry.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Graham
If former Minneapolis police officer Derek Chauvin's case for the death of George Floyd goes to trial, there will be this one, controversial legal principle looming over the proceedings: The reasonable officer. In this episode, we explore the origin of the reasonable officer standard, with the case that sent two Charlotte lawyers on a quest for true objectivity, and changed the face of policing in the US. This episode was produced by Matt Kielty with help from Kelly Prime and Annie McEwen. Support Radiolab today at Radiolab.org/donate.